Notably, Mycobacterium paragordonae (Mpg), a putative tuberculosis vaccine candidate (23), has been shown to elicit more robust immune responses in vaccinated mice studied as tuberculosis (24) or cancer vaccine models (25) than BCG. This evidence concerns the gene MPG and tuberculosis.